HUP9801686A3 - Use of aminotetralin derivative for producing pharmaceutical for the therapy of cardiovascular diseases - Google Patents
Use of aminotetralin derivative for producing pharmaceutical for the therapy of cardiovascular diseasesInfo
- Publication number
- HUP9801686A3 HUP9801686A3 HU9801686A HUP9801686A HUP9801686A3 HU P9801686 A3 HUP9801686 A3 HU P9801686A3 HU 9801686 A HU9801686 A HU 9801686A HU P9801686 A HUP9801686 A HU P9801686A HU P9801686 A3 HUP9801686 A3 HU P9801686A3
- Authority
- HU
- Hungary
- Prior art keywords
- therapy
- cardiovascular diseases
- producing pharmaceutical
- aminotetralin derivative
- aminotetralin
- Prior art date
Links
- JRZGPXSSNPTNMA-UHFFFAOYSA-N 1,2,3,4-tetrahydronaphthalen-1-amine Chemical class C1=CC=C2C(N)CCCC2=C1 JRZGPXSSNPTNMA-UHFFFAOYSA-N 0.000 title 1
- 208000024172 Cardiovascular disease Diseases 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/556—Angiotensin converting enzyme inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Vascular Medicine (AREA)
- Organic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT95MI000532A IT1275935B1 (it) | 1995-03-17 | 1995-03-17 | Derivato di aminotetralina per la terapia di malattie cardiovascolari |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP9801686A2 HUP9801686A2 (hu) | 1999-06-28 |
| HUP9801686A3 true HUP9801686A3 (en) | 1999-10-28 |
Family
ID=11370947
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9801686A HUP9801686A3 (en) | 1995-03-17 | 1996-03-13 | Use of aminotetralin derivative for producing pharmaceutical for the therapy of cardiovascular diseases |
Country Status (31)
| Country | Link |
|---|---|
| US (2) | US6013678A (hu) |
| EP (2) | EP0814791B1 (hu) |
| JP (1) | JPH11502211A (hu) |
| KR (1) | KR100391143B1 (hu) |
| CN (1) | CN1112920C (hu) |
| AT (1) | ATE218856T1 (hu) |
| AU (1) | AU702656B2 (hu) |
| BR (1) | BR9607996A (hu) |
| CA (1) | CA2215671A1 (hu) |
| CZ (1) | CZ288488B6 (hu) |
| DE (1) | DE69621786T2 (hu) |
| DK (1) | DK0814791T3 (hu) |
| EA (1) | EA000937B1 (hu) |
| EE (1) | EE04040B1 (hu) |
| ES (1) | ES2177769T3 (hu) |
| HK (2) | HK1004802A1 (hu) |
| HU (1) | HUP9801686A3 (hu) |
| IL (1) | IL117518A (hu) |
| IT (1) | IT1275935B1 (hu) |
| LT (1) | LT4355B (hu) |
| LV (1) | LV11882B (hu) |
| MX (1) | MX9706971A (hu) |
| NO (1) | NO317402B1 (hu) |
| NZ (1) | NZ303993A (hu) |
| PL (1) | PL183347B1 (hu) |
| PT (1) | PT814791E (hu) |
| SI (1) | SI9620036B (hu) |
| SK (1) | SK282952B6 (hu) |
| TR (1) | TR199700963T1 (hu) |
| WO (1) | WO1996029065A2 (hu) |
| ZA (1) | ZA962073B (hu) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2695157B2 (ja) * | 1986-12-29 | 1997-12-24 | 松下電器産業株式会社 | 可変パイプラインプロセッサ |
| WO2000076544A1 (en) * | 1996-03-13 | 2000-12-21 | Chiesi Farmaceutici S.P.A. | Aminotetralin derivative for the therapy of cardiovascular diseases |
| DE60004996T2 (de) * | 1999-06-09 | 2004-07-22 | Chiesi Farmaceutici S.P.A. | Aminotetralin derivate zur therapie der kardiovaskulären erkrankungen |
| EP1331004A3 (en) * | 1999-06-09 | 2003-08-06 | CHIESI FARMACEUTICI S.p.A. | Aminotetralin Derivative for the Therapy of Cardiovascular Diseases |
| IT1313583B1 (it) * | 1999-07-30 | 2002-09-09 | Chiesi Farma Spa | Derivati 2-amminotetralinici per la terapia del glaucoma. |
| IL152751A0 (en) * | 2000-05-12 | 2003-06-24 | Chiesi Farma Spa | Optically active 2-aminotetralin derivatives, the processes for the preparation thereof and the therapeutical use of pharmaceutical compositions containing them |
| SE0101854L (sv) * | 2001-05-28 | 2002-11-29 | Bioneris Ab | Användning av en förening med en negativt laddad region av grupper för behandling av restenos. |
| EP1384708A1 (en) * | 2002-07-26 | 2004-01-28 | CHIESI FARMACEUTICI S.p.A. | Process for the manufacture of form I of nolomirole hydrochloride |
| US20050101668A1 (en) * | 2003-07-24 | 2005-05-12 | Chiesi Farmaceutici S.P.A. | Aminotetralin derivatives as a medicament for the treatment and prevention of myocardial ischemic conditions |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4134997A (en) * | 1977-03-01 | 1979-01-16 | University Of Iowa Research Foundation | Effect of an aminotetralin derivative on coronary blood flow in infarcted hearts |
| SU998342A1 (ru) | 1981-12-11 | 1983-02-23 | Предприятие П/Я А-3732 | Способ получени синтетического цеолита типа @ |
| IT1218322B (it) * | 1982-06-10 | 1990-04-12 | Chiesi Farma Spa | Derivati di 1,2,3,4-tetraidronaftalene,procedimento di preparazione e relative composizioni farmaceutiche |
-
1995
- 1995-03-17 IT IT95MI000532A patent/IT1275935B1/it active IP Right Grant
-
1996
- 1996-03-13 ES ES96907446T patent/ES2177769T3/es not_active Expired - Lifetime
- 1996-03-13 DK DK96907446T patent/DK0814791T3/da active
- 1996-03-13 DE DE69621786T patent/DE69621786T2/de not_active Expired - Fee Related
- 1996-03-13 TR TR97/00963T patent/TR199700963T1/xx unknown
- 1996-03-13 WO PCT/EP1996/001060 patent/WO1996029065A2/en not_active Application Discontinuation
- 1996-03-13 JP JP8528045A patent/JPH11502211A/ja not_active Ceased
- 1996-03-13 EP EP96907446A patent/EP0814791B1/en not_active Expired - Lifetime
- 1996-03-13 KR KR1019970706438A patent/KR100391143B1/ko not_active IP Right Cessation
- 1996-03-13 EP EP02001772A patent/EP1216702A3/en not_active Withdrawn
- 1996-03-13 SI SI9620036A patent/SI9620036B/sl not_active IP Right Cessation
- 1996-03-13 PL PL96322284A patent/PL183347B1/pl not_active IP Right Cessation
- 1996-03-13 CN CN96193312A patent/CN1112920C/zh not_active Expired - Fee Related
- 1996-03-13 CZ CZ19972866A patent/CZ288488B6/cs not_active IP Right Cessation
- 1996-03-13 EE EE9700231A patent/EE04040B1/xx not_active IP Right Cessation
- 1996-03-13 MX MX9706971A patent/MX9706971A/es not_active IP Right Cessation
- 1996-03-13 EA EA199700243A patent/EA000937B1/ru not_active IP Right Cessation
- 1996-03-13 SK SK1254-97A patent/SK282952B6/sk unknown
- 1996-03-13 NZ NZ303993A patent/NZ303993A/xx unknown
- 1996-03-13 HU HU9801686A patent/HUP9801686A3/hu unknown
- 1996-03-13 AT AT96907446T patent/ATE218856T1/de not_active IP Right Cessation
- 1996-03-13 US US08/913,363 patent/US6013678A/en not_active Expired - Fee Related
- 1996-03-13 CA CA002215671A patent/CA2215671A1/en not_active Abandoned
- 1996-03-13 BR BR9607996A patent/BR9607996A/pt not_active Application Discontinuation
- 1996-03-13 PT PT96907446T patent/PT814791E/pt unknown
- 1996-03-13 AU AU51072/96A patent/AU702656B2/en not_active Ceased
- 1996-03-14 ZA ZA962073A patent/ZA962073B/xx unknown
- 1996-03-17 IL IL11751896A patent/IL117518A/en not_active IP Right Cessation
-
1997
- 1997-09-15 LT LT97-147A patent/LT4355B/lt not_active IP Right Cessation
- 1997-09-15 LV LVP-97-166A patent/LV11882B/en unknown
- 1997-09-16 NO NO19974267A patent/NO317402B1/no not_active IP Right Cessation
-
1998
- 1998-05-12 HK HK98104093A patent/HK1004802A1/xx not_active IP Right Cessation
-
1999
- 1999-06-09 US US09/328,434 patent/US6103760A/en not_active Expired - Fee Related
-
2002
- 2002-12-19 HK HK02109206.9A patent/HK1048060A1/zh unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1009939A1 (en) | Medicament for treating cardiac inflammatory diseases | |
| AU2639695A (en) | Novel uses of triplex forming oligonucleotides for the treatment of human diseases | |
| IL121170A0 (en) | Compositions for the treatment of dermatological disorders | |
| HUT71582A (en) | Potentiation of drug response | |
| EP0759306A3 (en) | Device for administering medication | |
| AU7867994A (en) | Hemofiltration of mediator-related diseases | |
| PL327628A1 (en) | Method of fighting against the expression of gene cd 44 for therapeutic purposes | |
| HUP9904317A3 (en) | Use of 1-hydroxy-2-pyridones for producing pharmaceutical compositions suitable for the treatment of skin diseases | |
| AU6858996A (en) | Pharmaceutical compositions for the treatment of infectious diseases | |
| HUP9801686A3 (en) | Use of aminotetralin derivative for producing pharmaceutical for the therapy of cardiovascular diseases | |
| AU9173191A (en) | Medicaments for the treatment of papillomavirus diseases | |
| AU5053296A (en) | Pharmaceutical agents for the treatment of Alzheimer's disease | |
| HUP9901303A3 (en) | A pharmaceutical composition for the treatment of autoimmune diseases | |
| EP0765661A3 (en) | Use of docosahexaenoic acid for the manufacture of a medicament for the treatment of glumerulonephritis | |
| AU7719791A (en) | Therapeutic product | |
| EP0790062A4 (en) | REMEDY FOR HEART DISEASE | |
| AU6369396A (en) | Drug for ameliorating brain diseases | |
| HUP9900309A3 (en) | Use of ridogrel for producing pharmaceutical compositions for the treatment of inflammatory bowel diseases | |
| AU2265695A (en) | The use of sertraline to treat cancer patients | |
| AU7726796A (en) | Use of 3-oxa-d-prostaglandins for the manufacture of a medicament for the treatment of glaucoma | |
| HUP9801925A3 (en) | Use of sodium-hydrogen-exchange-inhibitors for producing pharmaceutical compositions treating diseases caused by protozoons | |
| HUP9900170A3 (en) | Zwitterionic forms of trovafloxacin, process for producing them and medicaments containing the same | |
| GB9524942D0 (en) | Drug therapy | |
| SI0778025T1 (en) | Use of 8,9-dehydroestrone for the manufacture of a medicament for the treatment of diseases caused by free radicals | |
| IL135171A0 (en) | Use of glycosaminoglycans for producing pharmaceutical preparations for treating diabetes-associated diseases of the eye |